Latest Blogs

Aug 09, 2018
"You're an oncologist? How can you do it?" Radiation oncologists chimed in on Twitter about the rewards of the job.
Aug 08, 2018
Dr. Raj Mohan looks at surgical oncology through the lens of the saying that "the proof of the pudding is in the eating": ultimately, the outcome matters more than the process.
Aug 07, 2018
I spoke with our current ASCO president about her theme for the year, her work with the Alliance for Clinical Trials in Oncology, and her frontier spirit.
Aug 06, 2018
A patient who refused chemotherapy offered Dr. Erika Hamilton a lesson in compromise. 
Subscribe to this column

Gilberto Lopes, MD, MBA

Gilberto de Lima Lopes Jr., MD, MBA, FAMS, a medical oncologist, is medical director for international programs and associate director for global oncology at the Sylvester Comprehensive Cancer Center and associate professor of clinical medicine at the University of Miami in Florida. He returned to the United States after 10 years in Asia and Latin America and has dedicated much of his time to the issues of cancer control and access to medications in low- and middle-income countries. Dr. Lopes is the editor in chief of ASCO's Journal of Global Oncology, associate editor for the ASCO University Editorial Board, 2016-2017 chair of the International Clinical Trials Workshop Working Group, and global health track leader for the Cancer Education Committee, among other volunteer roles. Follow him on Twitter @GlopesMd.

Nov 20, 2017
A journal that aims to be the voice of global oncology has to publish work relating not only to differences in cancer biology due to risk factors, pathogenesis, and pharmacology, but also disparities arising from social, cultural, economic, and political resource-constraining issues.
Jul 26, 2017
My coauthors and I identify deficiencies in prevention and screening efforts that could be acted upon to further reduce cervical cancer incidence and mortality in Latin America.
Mar 20, 2017
When the basics of cancer control are not in place, should we discuss targeted agents and immunotherapy in resource-constrained settings?
Oct 31, 2016
Hope springs eternal in the Brazilian economy and health care system, with cautious optimism for gains in oncology care.
Oct 04, 2016
Inequalities, especially in health care, breed discontent. We need better ways to continue incentivizing the development of new drugs while optimizing access. Biosimilars help, but they won't solve the whole problem.
Aug 01, 2016
The region has seen structural reforms in health care systems, better training of cancer professionals, new initiatives for populations at high risk, expansion of cancer registries and cancer plans, and implementation of policies to improve prevention, early diagnosis, and treatment.

Pages